Proof of Concept of Single Application of AL-60371/AL-817 Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes Compared to CIPRODEX® (BID for 7 Days)
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2018
Price : $35 *
At a glance
- Drugs Finafloxacin/AL 817 (Primary) ; Ciprofloxacin/dexamethasone
- Indications Bacterial infections; Otorrhoea
- Focus Proof of concept; Therapeutic Use
- Sponsors Alcon
- 27 Aug 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Apr 2014 Planned End Date changed from 1 Apr 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 20 Jan 2014 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov